Story thread · 2 reports / 2 sources
STAT+: Neurocrine Biosciences rare disease drug possibly tied to safety issues, experts say
statnews.com · 4h · first report
How the coverage leans
Across 2 sources · syndicated copies counted once
A newly approved drug for Prader-Willi syndrome, a rare disease that causes an insatiable desire to eat, may be tied to a series of patient deaths, experts say.
The coverage
- Why is Neurocrine Biosciences stock down today?
investing.com · 2h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.